logo
RFK Jr. to face HELP panel in HHS bid

RFK Jr. to face HELP panel in HHS bid

Politico30-01-2025

Presented by The Pharmaceutical Reform Alliance
Driving the Day
KENNEDY'S NEXT TEST — Robert F. Kennedy Jr., President Donald Trump's choice to lead HHS, appears before a key Senate health committee stacked with lawmakers who could cast the deciding vote for or against him, I report with my colleagues Lauren Gardner and Daniel Payne.
The Senate Health, Education, Labor and Pensions Committee is holding a courtesy confirmation hearing for Kennedy one day after he appeared before the Senate Finance Committee, which will decide whether to recommend his confirmation to the Senate.
During his testimony before the Finance Committee on Wednesday, Kennedy tried to shed his history of anti-vaccine activism or speak broadly about the need for the U.S. government to address the rise of chronic disease. During questioning by Sen. Bill Cassidy (R-La.), who chairs the HELP Committee, Kennedy appeared to confuse Medicare and Medicaid.
What to expect today: More questioning on Kennedy's anti-vaccine rhetoric and public health views is likely today, given the HELP Committee's jurisdiction over public health agencies like the CDC and the FDA, which play key roles in monitoring and regulating vaccines.
He could also field questions from lawmakers who want commitments on their policy priorities, as they did at the Finance hearing. Sen. Chuck Grassley (R-Iowa) issued a statement Wednesday touting Kennedy's support for focusing on rural health care improvements and reining in pharmacy middlemen.
Why it matters: Though the HELP Committee won't vote to advance Kennedy's confirmation to the Senate floor, his answers could make the difference in whether he ultimately helms the federal government's health agencies. The exchanges with key senators Wednesday might suggest whether Kennedy's plans for sweeping reforms and reframing the government's role in U.S. health care will come to fruition.
The senators to watch include:
— Cassidy, who's maintained a poker face about how he's leaning. He might continue his questioning on Kennedy's policy priorities when it comes to federal health programs.
— Sens. Lisa Murkowski (R-Alaska), who said earlier this week she wants to 'drill down on and try to get some commitments' from Kennedy, and Susan Collins (R-Maine). On Saturday, both lawmakers voted against Pete Hegseth, Trump's pick to lead the Pentagon.
— Sen. Bernie Sanders (I-Vt.) said he liked Kennedy's adopted slogan, Make America Healthy Again, but sparred with him over whether health care should be a human right and his decision to put aside his past support for abortion rights to serve Trump, Sanders could also pick up on a line of questioning started by his colleague Sen. Elizabeth Warren (D-Mass.) on Kennedy's potential financial gain from lawsuits against drug companies.
WELCOME TO THURSDAY PULSE. Opponents wearing Make Polio Great Again T-shirts and supporters wearing Make America Healthy Again hats came face to face Wednesday at Robert F. Kennedy Jr.'s confirmation hearing. According to Capitol Police, six people were arrested for interrupting the hearing. What will we see today at the Senate HELP hearing? Send your tips, scoops and feedback to ccirruzzo@politico.com and follow along @ChelseaCirruzzo.
In Congress
HEALTH POLICY? NOT NOW — Robert F. Kennedy Jr. appeared shaky on some finer health policy points during his Senate Finance confirmation hearing Wednesday — but his supporters aren't worried.
Kennedy seemed to confuse Medicaid with the federal insurer for older Americans, Medicare, and struggled to answer a question about HHS' role in ensuring hospitals follow a longtime law requiring emergency rooms to treat patients regardless of their ability to pay.
Calley Means, a former food industry lobbyist-turned-adviser to Kennedy, suggested on social media that some senators focused their questioning on arcane policy issues.
'While he is being questioned about minutiae, he continually raises the conversation to the existential stakes of our chronic disease crisis,' Means posted on Instagram as Sen. Ben Ray Luján (D-N.M.) grilled Kennedy about Medicaid.
Later, at a Heritage Foundation reception for Kennedy supporters and the Make America Healthy Again PAC, Means told reporters that Kennedy's agenda on reducing chronic illness would eventually lead to federal health insurance policy change, saying 'standards of care' must be reworked.
'I think inevitably you'd have public policy decisions and administrative decisions around, potentially codes for Medicare, Medicaid, that come out of that science,' he said.
Sen. Ron Johnson (R-Wis.), co-founder of the Senate Make America Healthy Again caucus, devoted to advancing Kennedy's agenda, also criticized his colleagues' line of questioning.
'This is not a hearing to get into the details of a particular program that is mind-numbingly complex to begin with,' he told reporters outside the hearing room. 'These hearings are about 'What is your intention, what are your goals?''
Abortion
ANTI-ABORTION GROUP'S ENVIRONMENTAL PUSH — A cadre of red and purple states is introducing bills this week to impose restrictions on abortion pills over claims that the drugs could be contaminating drinking water, POLITICO's Alice Miranda Ollstein and Ariel Wittenberg report.
The new legislation in Arizona, Idaho, Maine, West Virginia and Wyoming — which would require doctors who prescribe abortion pills to make their patients collect and return their expelled fetuses in medical waste bags for disposal — is the latest development in anti-abortion groups' yearslong campaign to wield environmental laws to cut off access to the drugs.
The group leading the push, Students for Life of America, is also preparing lawsuits, federal bills and a pressure campaign aimed squarely at the environmental inclinations of Robert F. Kennedy Jr., who could soon lead the health agencies that regulate access to the pills.
Students for Life and its lawmaker allies claim that as women increasingly use the pills at home to end pregnancies and flush the expelled tissue, trace amounts of the drug make their way into rivers and streams where they can harm endangered species and livestock.
The group, which recently conducted its own testing in three U.S. cities and hopes to publish the results in a peer-reviewed medical journal later this year, has also claimed that the drug contaminates tap water and could threaten human fertility.
Multiple environmental health experts told POLITICO that no evidence supports those claims. But they could be convincing to Kennedy, an environmental attorney who said during his confirmation hearing Wednesday that he plans to investigate the safety of abortion pills.
Global Health
U.S. TIME IN WHO TICKS DOWN — The U.S. has begun its one-year countdown to withdraw from the World Health Organization, POLITICO's Carmen Paun reports.
The U.S. officially ends its membership on Jan. 22, 2026, according to a letter to the U.N. secretary-general and viewed by POLITICO.
The letter doesn't provide a reason for the withdrawal. In an Inauguration Day executive order, President Donald Trump cited 'unfairly onerous payments from the United States, far out of proportion with other countries' assessed payments.'
In 2020, during his first term, Trump threatened to withdraw, accusing the WHO of covering up Chinese negligence at the outset of the Covid-19 pandemic. He couldn't complete the withdrawal because he lost that year's election. President Joe Biden reversed the withdrawal plan.
Why it matters: The notification squashes doubts about the current U.S. intention to withdraw and sets a clear deadline.
The WHO will lose hundreds of millions of dollars in mandatory and voluntary contributions from the U.S., which will be excluded from a global network that decides the yearly makeup of the flu vaccine based on circulating strains.
Trump has touted the planned withdrawal in several speeches over the last few days and noted in one that he didn't expect the withdrawal to be so popular.
The WHO said it hoped the U.S. would reconsider withdrawing in a statement last week.
WHAT WE'RE READING
POLITICO's Kyle Cheney and Josh Gerstein report on a second judge preparing to block the White House's federal funding freeze.
POLITICO's Adam Cancryn reports on Robert F. Kennedy Jr.'s anti-vaccine group's response to his confirmation hearing.
The Associated Press reports on a tuberculosis outbreak in Kansas.
STAT reports on faltering mental health services despite the launch of a crisis hotline.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Castro to seek reelection to state Senate rather than make U.S. House bid
Castro to seek reelection to state Senate rather than make U.S. House bid

Chicago Tribune

time5 minutes ago

  • Chicago Tribune

Castro to seek reelection to state Senate rather than make U.S. House bid

State Sen. Cristina Castro, D-Elgin, has announced she will seek reelection to her District 22 post rather than make a bid next year for the Congressional seat being vacated by U.S. Rep. Raja Krisnamoorthi. 'When I first entered public service, it was with a singular goal: to deliver for my community and make life better for the people of the 22nd District, who I've been lucky to call my neighbors for my entire life,' Castro said in a news release. 'Over the past eight years as state senator, I'm proud to have stayed true to that mission — delivering real results and championing the working families of my district. As I think about the future and how I can continue to make the biggest impact, that goal remains my North Star.' In addition to Elgin, Castro's district encompasses all or part of 10 communities in Cook and Kane counties. Her statement came the same week that state Rep. Anna Moeller, D-Elgin, also announced she also would seek reelection to the House instead of making a bid for Congress. Krishnamoorthi, who represents the 8th District in the U.S. House, has announced plans to run in the primary for the seat currently held by U.S. Sen. Dick Durbin, who plans to retire. Both he and Durbin are Democrats, as are two other candidates who have announced they're running for the job: Lt. Gov. Juliana Stratton and U.S. Rep. Robin Kelly, D-Matteson. Castro, elected to the state Senate in 2016, is the majority caucus whip for the 103rd General Assembly, chair of the Senate Executive Committee, and a member of the Latino Caucus, according to her website biography. She serves on the Appropriations, Energy and Public Utilities, Insurance, Labor and Revenue committees. Prior to being elected to the state Senate, she served on the Kane County Board from 2008 to 2016. Castro holds an associate degree from Elgin Community College and bachelor's and master's degree in business administration from Northern Illinois University.

'Scapegoating entire nations.' Trump's travel ban hurts innocent Columbus families
'Scapegoating entire nations.' Trump's travel ban hurts innocent Columbus families

Yahoo

time13 minutes ago

  • Yahoo

'Scapegoating entire nations.' Trump's travel ban hurts innocent Columbus families

Farxaan Jeyte is a seasoned political strategist, entrepreneur and advocate with over 20 years of experience in U.S. presidential, gubernatorial and Senate campaigns. He is active in U.S.–Africa policy and supports minority-owned businesses through his work in trade, governance and grassroots advocacy. Donald Trump's administration argues that banning citizens of 12 countries — Somalia included — from entering the United States will fill gaps in foreign vetting and prevent dangerous individuals from slipping through. The move came after an Egyptian national was arrested on charges that he firebombed a pro-Israel rally in Boulder, Colorado. Trump said the attack 'underscored the extreme dangers posed by foreign nationals who are not properly vetted.' White House officials call the move 'commonsense' and say it targets countries with weak screening and high visa overstay rates to 'protect Americans from dangerous foreign actors.' Yet for all the focus on security, the human costs of a blanket ban are impossible to ignore. The policy casts a wide net, halting travel for entire populations because of the actions of a few. It sweeps up people who pose no threat: students, grandparents and refugees. More: Habiba Soliman wanted to be a doctor. Then, her father firebombed Jewish marchers in Boulder Punishing whole nations for the crimes of individuals also raises basic fairness issues. Notably, the Boulder suspect's country of origin, Egypt, isn't even on the ban list, calling into question how effective banning other countries really is. From the administration's view, the Boulder attack was a wake-up call revealing flaws in the immigration system. Officials note the suspect was an Egyptian visitor who overstayed his visa — a failure of enforcement they cite as proof of lax vetting. Supporters of the ban point out that many listed nations are unstable, potentially allowing extremists to slip through. By halting entry from countries such as Afghanistan, Yemen and Somalia — all grappling with terrorism — the administration contends it is closing dangerous loopholes to prevent another tragedy. Critics argue the collateral damage — broken families and lost trust — far outweighs any security benefit. Human rights groups have decried the renewed policy as 'discriminatory' and cruel, saying it 'sows division and vilifies communities' seeking safety. The consequences for innocent families will be devastating. Ohio has roughly 60,000 Somali-American residents in the Columbus area. This vibrant community has contributed enormously — immigrants from Somalia have opened hundreds of local businesses and enriched the city's culture. More: 'Nobody told us about the neighborhood': Somali Americans experiences with youth violence A ban on Somalia strikes at the heart of these families. Grandparents may miss the birth of a grandchild, and students could see siblings barred from graduations. In Columbus, conversations are filled with concern for relatives stranded abroad. People who once fled terror and found refuge in America now worry they're seen as threats. It's a painful irony that has left many feeling alienated in the only country they call home. Trump's 2017 travel ban on Muslim-majority countries like Somalia caused chaos at airports and tore families apart — a history now poised to repeat. One Somali refugee in Ohio was separated from his wife and children for nearly seven years due to that ban. We can protect America without scapegoating entire nations. Rather than broad bans, officials should pursue targeted, intelligence-based measures — stronger background checks, better visa enforcement and vetting individuals based on real red flags, not blanket nationality. U.S. agencies are capable of pinpointing threats without closing the door on innocent travelers. Blanket travel bans offer a false sense of security while breeding resentment. A wiser approach balances vigilance with fairness, preserving goodwill with immigrant communities. Somali-Americans have proven their commitment to this country and should be treated as partners in safety, not suspects. Focusing on genuine threats — instead of scapegoating entire populations — is more just and more effective at keeping America safe. Farxaan Jeyte is a seasoned political strategist, entrepreneur and advocate with over 20 years of experience in U.S. presidential, gubernatorial and Senate campaigns. He is active in U.S.–Africa policy and supports minority-owned businesses through his work in trade, governance and grassroots advocacy. This article originally appeared on The Columbus Dispatch: Trump's travel ban lists countries with strong Ohio ties | Opinion

Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory
Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory

Yahoo

time20 minutes ago

  • Yahoo

Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory

We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. (REGN) on Notes From The Beauty Contest's Substack. In this article, we will summarize the bulls' thesis on REGN. Regeneron Pharmaceuticals, Inc. (REGN)'s share was trading at $605.39 as of 29th May. REGN's trailing and forward P/E were 15.39 and 17.39 respectively according to Yahoo Finance. A scientist in a lab conducting research on cell-based therapeutics and biotechnology. Regeneron's latest earnings report was notably weak, with a 3.7% revenue decline and a 14% EPS drop, surprising given the company's history of exceeding market expectations. The primary driver was a steep 26% year-over-year decline in the U.S. Eylea franchise, particularly a 39% drop in 2mg Eylea sales. This was partly due to a co-pay assistance funding gap, which forced many Medicare patients to switch to cheaper alternatives like compounded Avastin, impacting both Regeneron and rival Roche's Vabysmo. Regeneron, having contributed over $400 million last year to charitable foundations supporting co-pay assistance, is now seeking to share this burden, proposing a matching donation program to encourage broader industry support. Another setback was the FDA's Complete Response Letter delaying approval of the Eylea-HD pre-filled syringe, a key product needed to compete with Vabysmo. The delay stemmed from third-party component issues rather than drug efficacy, and management believes resolution could be near. Margins also contracted, with gross margin falling from 89% to 85% due to unspecified inventory write-offs, possibly related to older Eylea 2mg or even leftover REGEN-COV stock. However, the margin pressure appears more tied to one-offs and increased R&D spending than structural issues. On a more positive note, Regeneron's pipeline is broadening meaningfully. Itepekimab, an IL-33 antibody, shows promise as a major respiratory asset with pivotal COPD data upcoming and expanded trials underway. The growing RNAi pipeline, now at nine siRNAs through its Alnylam collaboration, signals Regeneron's potential evolution beyond antibodies into a broader genetic medicine powerhouse. Regeneron Pharmaceuticals, Inc. (REGN) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 66 hedge fund portfolios held REGN at the end of the first quarter which was 68 in the previous quarter. While we acknowledge the potential of LYFT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store